Back to Search
ANDREW ZALEWSKI, M.D.
Specialist
NPI: 1457784282Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD031595E(PA)
Research & Publications (20)
Lipoprotein-associated phospholipase A2: a potential therapeutic target for atherosclerosis.
PMID 16503872·Curr Drug Targets Cardiovasc Haematol Disord·2005
6-review
Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target.
PMID 15731492·Arterioscler Thromb Vasc Biol·2005
6-review
The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
PMID 19477353·J Am Coll Cardiol·2009
2-rct
Landscape barriers reduce gene flow in an invasive carnivore: geographical and local genetic structure of American mink in Scotland.
PMID 19302354·Mol Ecol·2009
7-preclinical
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.
PMID 18806801·Nat Med·2008
7-preclinical
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics.
PMID 19033001·Am Heart J·2008
4-observational
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.
PMID 18765397·Circulation·2008
4-observational
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
PMID 18436114·J Am Coll Cardiol·2008
4-observational
Site-specific atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature.
PMID 18276914·Arterioscler Thromb Vasc Biol·2008
7-preclinical
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.
PMID 17301621·Eur J Cardiovasc Prev Rehabil·2007
1-meta
Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
PMID 16765356·Atherosclerosis·2007
7-preclinical
Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS).
PMID 16545642·J Am Coll Cardiol·2006
3-trial
Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target.
PMID 16495153·Curr Opin Pharmacol·2006
6-review
Parasites of carnivorous mammals in Białowieza Primeval Forest.
PMID 17007336·Wiad Parazytol·2006
7-preclinical
Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target.
PMID 16004595·Expert Opin Investig Drugs·2005
6-review
Lipoprotein-associated phospholipase A2 as a target of therapy.
PMID 15990594·Curr Opin Lipidol·2005
6-review
Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology.
PMID 16047125·Int J Cardiovasc Imaging·2005
8-other
[Is radiofrequency ablation indicated in asymptomatic patients with WPW Syndrome?].
PMID 15457288·Kardiol Pol·2004
5-case
Human epicardial adipose tissue is a source of inflammatory mediators.
PMID 14581396·Circulation·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 619 ELKINS AVE
ELKINS PARK, PA 19027 - Phone
- (215) 635-3353
Quick Facts
- NPI
- 1457784282
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile